Literature DB >> 31213653

Primary immunodeficiency with chronic enteropathy and developmental delay in a boy arising from a novel homozygous RIPK1 variant.

Yuri Uchiyama1,2, Chong A Kim3, Antonio Carlos Pastorino4, José Ceroni3, Patricia Picciarelli Lima5, Mayra de Barros Dorna4, Rachel Sayuri Honjo3, Débora Bertola3, Kohei Hamanaka1, Atsushi Fujita1, Satomi Mitsuhashi1, Satoko Miyatake1,6, Atsushi Takata1, Noriko Miyake1, Takeshi Mizuguchi7, Naomichi Matsumoto8.   

Abstract

Identification of genetic causes of primary monogenic immunodeficiencies would strengthen the current understanding of their immunopathology. Pathogenic variants in genes in association with tumor necrosis factor α (TNFα) signaling, including OTULIN, TNFAIP3, RBCK1, and RNF31 cause human congenital autoinflammatory diseases with/without immunodeficiency. RIPK1, encoding a receptor interacting serine/threonine kinase 1, is present in protein complexes mediating signal transduction including TNF receptor 1. Biallelic loss-of-function variants in RIPK1 were recently reported in individuals with primary immunodeficiency with intestinal bowel disease and arthritis. Here, we report a novel homozygous RIPK1 variant in a boy with immunodeficiency and chronic enteropathy. Our patient exhibited severe motor delay and mild intellectual disability, which were previously unknown. The present results are expected to deepen the current understanding of clinical features based on RIPK1 abnormalities.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31213653     DOI: 10.1038/s10038-019-0631-3

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  17 in total

1.  De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood.

Authors:  Hirotomo Saitsu; Taki Nishimura; Kazuhiro Muramatsu; Hirofumi Kodera; Satoko Kumada; Kenji Sugai; Emi Kasai-Yoshida; Noriko Sawaura; Hiroya Nishida; Ai Hoshino; Fukiko Ryujin; Seiichiro Yoshioka; Kiyomi Nishiyama; Yukiko Kondo; Yoshinori Tsurusaki; Mitsuko Nakashima; Noriko Miyake; Hirokazu Arakawa; Mitsuhiro Kato; Noboru Mizushima; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2013-02-24       Impact factor: 38.330

2.  Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth.

Authors:  Menachem Fromer; Jennifer L Moran; Kimberly Chambert; Eric Banks; Sarah E Bergen; Douglas M Ruderfer; Robert E Handsaker; Steven A McCarroll; Michael C O'Donovan; Michael J Owen; George Kirov; Patrick F Sullivan; Christina M Hultman; Pamela Sklar; Shaun M Purcell
Journal:  Am J Hum Genet       Date:  2012-10-05       Impact factor: 11.025

Review 3.  MK2-TNF-Signaling Comes Full Circle.

Authors:  Manoj B Menon; Matthias Gaestel
Journal:  Trends Biochem Sci       Date:  2017-12-21       Impact factor: 13.807

4.  Accurate and exact CNV identification from targeted high-throughput sequence data.

Authors:  Alex S Nord; Ming Lee; Mary-Claire King; Tom Walsh
Journal:  BMC Genomics       Date:  2011-04-12       Impact factor: 3.969

5.  Detection of copy number variations in epilepsy using exome data.

Authors:  N Tsuchida; M Nakashima; M Kato; E Heyman; T Inui; K Haginoya; S Watanabe; T Chiyonobu; M Morimoto; M Ohta; A Kumakura; M Kubota; Y Kumagai; S-I Hamano; C M Lourenco; N A Yahaya; G-S Ch'ng; L-H Ngu; A Fattal-Valevski; M Weisz Hubshman; N Orenstein; D Marom; L Cohen; H Goldberg-Stern; Y Uchiyama; E Imagawa; T Mizuguchi; A Takata; N Miyake; H Nakajima; H Saitsu; S Miyatake; N Matsumoto
Journal:  Clin Genet       Date:  2018-01-25       Impact factor: 4.438

Review 6.  Lessons from characterization and treatment of the autoinflammatory syndromes.

Authors:  Ivona Aksentijevich; Michael F McDermott
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

7.  Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease.

Authors:  Qing Zhou; Xiaomin Yu; Erkan Demirkaya; Natalie Deuitch; Deborah Stone; Wanxia Li Tsai; Hye Sun Kuehn; Hongying Wang; Dan Yang; Yong Hwan Park; Amanda K Ombrello; Mary Blake; Tina Romeo; Elaine F Remmers; Jae Jin Chae; James C Mullikin; Ferhat Güzel; Joshua D Milner; Manfred Boehm; Sergio D Rosenzweig; Massimo Gadina; Steven B Welch; Seza Özen; Rezan Topaloglu; Mario Abinun; Daniel L Kastner; Ivona Aksentijevich
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-24       Impact factor: 11.205

8.  RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.

Authors:  James A Rickard; Joanne A O'Donnell; Joseph M Evans; Najoua Lalaoui; Ashleigh R Poh; TeWhiti Rogers; James E Vince; Kate E Lawlor; Robert L Ninnis; Holly Anderton; Cathrine Hall; Sukhdeep K Spall; Toby J Phesse; Helen E Abud; Louise H Cengia; Jason Corbin; Sandra Mifsud; Ladina Di Rago; Donald Metcalf; Matthias Ernst; Grant Dewson; Andrew W Roberts; Warren S Alexander; James M Murphy; Paul G Ekert; Seth L Masters; David L Vaux; Ben A Croker; Motti Gerlic; John Silke
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

9.  A novel SLC9A1 mutation causes cerebellar ataxia.

Authors:  Kazuhiro Iwama; Hitoshi Osaka; Takahiro Ikeda; Satomi Mitsuhashi; Satoko Miyatake; Atsushi Takata; Noriko Miyake; Shuichi Ito; Takeshi Mizuguchi; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2018-07-17       Impact factor: 3.172

10.  Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.

Authors:  Qing Zhou; Hongying Wang; Daniella M Schwartz; Monique Stoffels; Yong Hwan Park; Yuan Zhang; Dan Yang; Erkan Demirkaya; Masaki Takeuchi; Wanxia Li Tsai; Jonathan J Lyons; Xiaomin Yu; Claudia Ouyang; Celeste Chen; David T Chin; Kristien Zaal; Settara C Chandrasekharappa; Eric P Hanson; Zhen Yu; James C Mullikin; Sarfaraz A Hasni; Ingrid E Wertz; Amanda K Ombrello; Deborah L Stone; Patrycja Hoffmann; Anne Jones; Beverly K Barham; Helen L Leavis; Annet van Royen-Kerkof; Cailin Sibley; Ezgi D Batu; Ahmet Gül; Richard M Siegel; Manfred Boehm; Joshua D Milner; Seza Ozen; Massimo Gadina; JaeJin Chae; Ronald M Laxer; Daniel L Kastner; Ivona Aksentijevich
Journal:  Nat Genet       Date:  2015-12-07       Impact factor: 38.330

View more
  7 in total

Review 1.  Regulatory mechanisms of RIPK1 in cell death and inflammation.

Authors:  Zhijun Liu; Francis Ka-Ming Chan
Journal:  Semin Cell Dev Biol       Date:  2020-06-29       Impact factor: 7.727

Review 2.  Targeting RIP Kinases in Chronic Inflammatory Disease.

Authors:  Mary Speir; Tirta M Djajawi; Stephanie A Conos; Hazel Tye; Kate E Lawlor
Journal:  Biomolecules       Date:  2021-04-28

Review 3.  Dysregulation of Cell Death in Human Chronic Inflammation.

Authors:  Yue Li; Christoph Klein; Daniel Kotlarz
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-07-01       Impact factor: 9.708

Review 4.  Primary immune regulatory disorders: a growing universe of immune dysregulation.

Authors:  Alice Y Chan; Troy R Torgerson
Journal:  Curr Opin Allergy Clin Immunol       Date:  2020-12

5.  The scaffold-dependent function of RIPK1 in dendritic cells promotes injury-induced colitis.

Authors:  Kenta Moriwaki; Christa Park; Kazuha Koyama; Sakthi Balaji; Kohei Kita; Ryoko Yagi; Sachiko Komazawa-Sakon; Manami Semba; Tatsuya Asuka; Hiroyasu Nakano; Yoshihiro Kamada; Eiji Miyoshi; Francis K M Chan
Journal:  Mucosal Immunol       Date:  2021-08-30       Impact factor: 7.313

Review 6.  Rare catastrophes and evolutionary legacies: human germline gene variants in MLKL and the necroptosis signalling pathway.

Authors:  Sarah E Garnish; Joanne M Hildebrand
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

7.  Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation.

Authors:  Huipeng Jiao; Laurens Wachsmuth; Snehlata Kumari; Robin Schwarzer; Juan Lin; Remzi Onur Eren; Amanda Fisher; Rebecca Lane; George R Young; George Kassiotis; William J Kaiser; Manolis Pasparakis
Journal:  Nature       Date:  2020-03-25       Impact factor: 49.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.